Journalartikel
Autorenliste: Keranov, Stanislav; Doerr, Oliver; Jafari, Leili; Liebetrau, Christoph; Keller, Till; Troidl, Christian; Riehm, Jessica; Rutsatz, Wiebke; Bauer, Pascal; Kriechbaum, Steffen; Voss, Sandra; Richter, Manuel J.; Tello, Khodr; Gall, Henning; Ghofrani, Hossein A.; Guth, Stefan; Seeger, Werner; Hamm, Christian W.; Nef, Holger
Jahr der Veröffentlichung: 2021
Seiten: 1021-1034
Zeitschrift: Biomarkers in Medicine
Bandnummer: 15
Heftnummer: 12
ISSN: 1752-0363
eISSN: 1752-0371
DOI Link: https://doi.org/10.2217/bmm-2021-0009
Verlag: Taylor and Francis
Abstract:
Aim: This study assessed the utility of osteopontin (OPN) and galectin-3 (Gal-3) as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension (PH). Materials & methods: We examined plasma levels of OPN and Gal-3 in patients with PH (n = 62), dilated cardiomyopathy (n = 34), left ventricular hypertrophy (LVH; n = 47), and controls without right ventricle (RV) or LV abnormalities (n = 38). Results: OPN and Gal-3 levels were higher in PH, dilated cardiomyopathy and LVH than in the controls. OPN concentrations in PH patients with maladaptive RV were significantly higher than in those with adaptive RV. Gal-3 did not differentiate between adaptive and maladaptive RV remodeling in PH. OPN and Gal-3 levels did not correlate with parameters of LV remodeling. Conclusion: OPN is a potential biomarker of RV maladaptation.
Zitierstile
Harvard-Zitierstil: Keranov, S., Doerr, O., Jafari, L., Liebetrau, C., Keller, T., Troidl, C., et al. (2021) Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension, Biomarkers in Medicine, 15(12), pp. 1021-1034. https://doi.org/10.2217/bmm-2021-0009
APA-Zitierstil: Keranov, S., Doerr, O., Jafari, L., Liebetrau, C., Keller, T., Troidl, C., Riehm, J., Rutsatz, W., Bauer, P., Kriechbaum, S., Voss, S., Richter, M., Tello, K., Gall, H., Ghofrani, H., Guth, S., Seeger, W., Hamm, C., & Nef, H. (2021). Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension. Biomarkers in Medicine. 15(12), 1021-1034. https://doi.org/10.2217/bmm-2021-0009
Schlagwörter
CTEPH; DCM; FIBROSIS; HEART-FAILURE; IPAH; LV-hypertrophy; RV-PA coupling